Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1484 Neoplasms 1101 Carcinoma, Non-Small-Cell Lung 918 Prostatic Neoplasms 802 Multiple Myeloma 586 Colorectal Neoplasms 535 Leukemia, Myeloid, Acute 505 Lung Neoplasms 489 Lymphoma 455 Melanoma 454 Neoplasm Metastasis 451 Lymphoma, Non-Hodgkin 416 Leukemia 409 Leukemia, Lymphocytic, Chronic, B-Cell 366 Ovarian Neoplasms 357 Pancreatic Neoplasms 338 Precursor Cell Lymphoblastic Leukemia-Lymphoma 334 Recurrence 315 Head and Neck Neoplasms 298 Lymphoma, Follicular 297 Myelodysplastic Syndromes 282 Carcinoma, Renal Cell 272 Glioblastoma 266 Brain Neoplasms 265 Hodgkin Disease 260 Lymphoma, Large B-Cell, Diffuse 255 Carcinoma, Hepatocellular 241 Lymphoma, Mantle-Cell 219 Squamous Cell Carcinoma of Head and Neck 214 Stomach Neoplasms 210

Interventions

Pregabalin 1 Capsaicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Has results × Breast Cancer Patient × Clear all

NCT03794388 2026-05-05

CAPTRANE

Institut Cancerologie de l'Ouest

Phase 3 Completed

140 enrolled 6 charts

Breast Cancer Patient

Data powered by HemOnc (CC BY 4.0) Colophon ⚡